Abnormal FHIT transcripts found in both lung cancer and normal lung tissue

Genes Chromosomes and Cancer

Volumn 24, Issue 2, 1999, Pages 105-111

  Tokuchi, Yoshio ^a   Kobayashi, Yasuhito ^a   Hayashi, Shin Ichi ^a   Hayashi, Moriaki ^a   Tanimoto, Keiji ^a   Hashimoto, Takehisa ^a   Nishida, Kazunori ^a   Ishikawa, Yuichi ^b   Nakagawa, Ken ^b   Satoh, Yukitoshi ^c   Yamamoto, Mitsunobu ^a   Tsuchiya, Eiju ^a  

^a SAITAMA CANCER CENTER   (Japan)

^b CANCER INSTITUTE   (Japan)

^c Japan Anti Tuberculosis Association   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; EXON; FEMALE; GENE LOCUS; GENETIC TRANSCRIPTION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LUNG CANCER; LUNG CARCINOGENESIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN PROCESSING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; SEQUENCE ANALYSIS;

ACID ANHYDRIDE HYDROLASES; FEMALE; GENETIC MARKERS; HUMANS; LOSS OF HETEROZYGOSITY; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0032901724     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199902)24:2<105::AID-GCC2>3.0.CO;2-P     Document Type: Article

References (27)

1. 3'-triphosphate, hydrolase. Biochemistry 35:11529-11535.
2. Chomczynski P, Sacchi N. 1987. Single-step methods of isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
3. Druck T, Hadaczek P, Fu T-B, Ohta M, Siprashvili Z, Baffa R, Negrini M, Kastury K, Veronese ML, Rosen D, Rothstein J, McCue P, Cotticelli MG, Inoue H, Croce CM, Huebner K. 1997. Structure and expression of human FHIT gene in normal and tumor cells. Cancer Res 57:2256-2267.
4. Fong KM, Biesterveld EJ, Virmani A, Wistuba I, Sekido Y, Baeder SA, Ahmadian M, Ong T, Rassool FV, Zimmerman PV, Giaccone G, Gazdar AF, Minna JD. 1997. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations. Cancer Res 57:2256-2267.
5. Gemma A, Hagiwara K, Ke Y, Burke LM, Khan MA, Nagashima M, Bennett WP, Harris CC. 1997. FHIT mutation in human primary gastric cancer. Cancer Res 57:1435-1437.
6. Harris C-C, Hollstein M. 1993. Clinical implications of the p53 tumor-suppressor gene. N Engl J Med 329:1318-1327.
7. Hayashi S-I, Tanimoto K, Hajiro-Nakanishi K, Tsuchiya E, Kurosumi M, Higashi Y, Imai K, Suga K, Nakachi K. 1997. Abnormal FHIT transcripts in human breast carcinomas: A clinicopathological and epidemiological analysis of 61 Japanese cases. Cancer Res 57:1981-1985.
8. Hendricks DT, Taylor R, Reed M, Birrer MJ. 1997. FHIT gene expression in human ovarian, endometrial, and cervical cancer cell lines. Cancer Res 57:2112-2115.
9. Hibi K, Takahashi T, Yamakawa K, Ueda R, Sekido Y, Ariyoshi Y, Suyama M, Takagi H, Nakamura Y, Takahashi T. 1992. Three distinct regions involved in 3p deletion in human lung cancer. Oncogene 7:445-449.
10. Hung J, Kishimoto Y, Sugio K, Virmani A, McIntire DD, Minna JD, Gazdar AF. 1995. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. JAMA 273:558-563.
11. International Union Against Cancer. 1993. TNM supplement 1993: A commentary on uniform use. Berlin: Springer-Verlag. p 34-36.
12. Mao L, Fan YH, Lotan R, Hong WK. 1996. Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines. Cancer Res 56:5128-5131.
13. Negrini M, Monaco C, Vorechovsky I, Ohta M, Druck T, Baffa R, Huebner K, Croce CM. 1996. The FHIT gene at 3p14.2 is abnormal in breast carcinomas. Cancer Res 56:4347-4350.
14. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T, Croce CM, Huebner K. 1996. The FHIT gene spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84:587-597.
15. Panagopoulos I, Thelin S, Mertens F, Mitelman F, Åman P. 1997. Variable FHIT transcripts in non-neoplastic tissues. Genes Chromosomes Cancer 19:215-219.
16. Sato S, Nakamura Y, Tsuchiya E. 1994. Difference of allelotype between squamous and adenocarcinoma. Cancer Res 54:5652-5655.
17. Siprashvili Z, Sozzi G, Barnes LD, McCue P, Robinson AK, Eryomin V, Sard L, Tagriabue E, Greco A, Fusseti L, Schwartz G, Pierotti MA, Croce CM, Huebner K. 1997. Replacement of Fhit in cancer cells suppresses tumorigenicity. Proc Natl Acad Sci USA 94:13771-13776.
18. Sozzi G, Veronese ML, Negrini M, Baffa R, Cotticelli MG, Inoue H, Tornielli S, Pilloti S, Gregorio LD, Pastorio U, Pierotti MA, Ohta M, Huebner K, Croce CM. 1996. The FHIT gene at 3p14.2 is abnormal in lung cancer. Cell 85:17-26.
19. Sozzi G, Sard L, Gregorio LG, Marchetti A, Musso K, Buttitta F, Tornielli S, Pellegrini S, Veronese ML, Manenti G, Incarbone M, Chella A, Angeletti CA, Pastorino U, Hueber K, Bevilaqua G, Pilotti S, Croce CM, Pierotti MA. 1997a. Association between cigarette smoking and FHIT gene alterations in lung cancer. Cancer Res 57:2121-2123.
20. Sozzi G, Tornielli S, Tagliabue E, Sard L, Pezzella F, Pastorino U, Minoletti F, Pilotti S, Ratcliffe C, Veronese ML, Goldstraw P, Hueber K, Croce CM, Pierotti MA. 1997b. Absence of Fhit protein in primary lung tumors and cell lines with FHIT gene abnormalities. Cancer Res 57:5207-5212.
21. Todd S, Franklin WA, Varella-Garcia M, Kennedy T, Hilliker CE Jr, Hahner L, Anderson M, Wiest JS, Drabkin A, Gemmili RM. 1997. Homozygous deletions of human chromosome 3p in lung tumors. Cancer Res 57:1344-1352.
22. Tsuchiya E, Nakamura Y, Weng S-Y, Nakagawa K, Tsuchiya S, Sugano H, Kitagawa T. 1992. Allelotype of non-small cell lung carcinoma - Comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma. Cancer Res 52:2478-2481.
23. Van den Berg A, Draaijers TG, Kok K, Timmer T, van den Veen AY, Veldhuis PMJF, de Leij L, Gerhartz CD, Naylor SL, Smith DI, Buys CHCM. 1997. Normal FHIT transcripts in renal cell cancer- and lung cancer-derived cell lines, including a cell line with homozygous deletion in the FRA3B regions. Genes Chromosomes Cancer 19:220-227.
24. Whang-Peng J, Kao-Shan CS, Lee EC. 1982. Specific chromosome defect associated with human small-cell lung cancer; deletion 3p(14-23). Science 215:181-182.
25. World Health Organization. 1981. Histological Typing of Lung Tumours. International Histological Classification of Tumors. 2nd Ed, Vol 1. Geneva: World Health Organization, p 19-32.
26. Yanagisawa K, Kondo M, Osada H, Uchida K, Takagi K, Masuda A, Takahashi T, Takahashi T. 1996. Molecular analysis of the FHIT gene at 3p14.2 in lung cancer cell lines. Cancer Res 56:5579-5582.
27. Yokota J, Wada M, Shimosato Y, Terada M, Sugimura T. 1987. Loss of heterozygosity on chromosome 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung. Proc Natl Acad Sci USA 84:9252-9256.